Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jul;14(7):2458-2460.
doi: 10.21037/jtd-22-705.

Mechanical complications of ST segment elevation myocardial infarction: are they tangible?

Seong Huan Choi  1 , Sung Woo Kwon  1
Affiliations
Editorial

Mechanical complications of ST segment elevation myocardial infarction: are they tangible?

Seong Huan Choi et al. J Thorac Dis. 2022 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-22-705/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Hosseini SK, Soleimani A, Karimi AA, et al. Clinical features, management and in-hospital outcome of ST elevation myocardial infarction (STEMI) in young adults under 40 years of age. Monaldi Arch Chest Dis 2009;72:71-6. - PubMed
    1. Szummer K, Wallentin L, Lindhagen L, et al. Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014. Eur Heart J 2017;38:3056-65. 10.1093/eurheartj/ehx515 - DOI - PMC - PubMed
    1. Lee MS, Pessegueiro A, Zimmer R, et al. Clinical presentation of patients with in-stent restenosis in the drug-eluting stent era. J Invasive Cardiol 2008;20:401-3. - PubMed
    1. Gershlick AH, Banning AP, Myat A, et al. Reperfusion therapy for STEMI: is there still a role for thrombolysis in the era of primary percutaneous coronary intervention? Lancet 2013;382:624-32. 10.1016/S0140-6736(13)61454-3 - DOI - PubMed
    1. Morrow DA, Antman EM, Snapinn SM, et al. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. Eur Heart J 2002;23:223-9. 10.1053/euhj.2001.2738 - DOI - PubMed